Inka Puhakka

发表

Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis

P. Jäkälä, E. Sonkajärvi, T. Selander, 2021, BMC cancer.

Primary Central Nervous System Lymphoma Increasing Incidence and Poor Survival: A Finnish Population-based Analysis

P. Jäkälä, E. Sonkajärvi, T. Selander, 2021 .

Blood–Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study

E. Jantunen, H. Littow, T. Selander, 2023, Cancers.

Rapid diagnosis and initiation of treatment has a crucial role in the prognosis of primary central nervous system lymphoma

P. Jäkälä, K. Sunela, T. Selander, 2023, British journal of haematology.